Artul 2014.

Methods	A patient report of severe recurrent pancreatitis during methylphenidate treatment
Participants	Diagnosis of ADHD: DSM (version and subtype: not stated) Age: 10 years old IQ: > 70 Sex: male Ethnicity: Arabic Country: Israel Comorbidity: none Comedication: none Sociodemographics: good socioeconomic status
Interventions	Methylphenidate dosage: 30 mg daily Administration schedule: not stated Duration of treatment: 3 weeks Treatment compliance: not stated
Outcomes	Serious adverse events: After 3 weeks of treatment at 30 mg/daily: severe relapsing pancreatitis, 3 times in 2 months within 3 weeks after starting treatment with methylphenidate. Discontinuation: free of symptoms
Notes	Key conclusions of the study authors: acute pancreatitis in paediatric age could be due to the use of methylphenidate Funding/vested interests: the authors have no conflicts of interest to disclose Authors' affiliations: Department of Radiology, Nazareth Hospital, EMMS, Faculty of Medicine, Bar‐Ilan University, Israel. Faculty of Medicine in the Galilee, Bar‐Ilan University, Safed, Israel Department of Nuclear Medicine, Meir Hospital, 44410 Betah Tekva, Israel. Department of Internal Medicine, EMMS Hospital, 16100 Nazareth, Israel. Pediatric Department, Nazareth Hospital, Israel Supplemental information regarding IQ, ethnicity, comorbidity and comedication received through personal email correspondence with the authors in August 2016. No information regarding exact IQ level was available, but authors state that it was above 70 (Artul 2016 [pers comm])